The Effect of Massage on Bilirubin Level in Infants
Investigation of the Effect of Massage on Bilirubin Level in Preterm Infants
1 other identifier
interventional
64
1 country
1
Brief Summary
Jaundice (hyperbilirubinemia) which is one of the common causes of repeated hospitalizations in the neonatal period, is a physiological condition seen in 60% of term babies and 80% of premature babies in the first week of life . Premature babies are more susceptible tobilirubin neurotoxicity. Death and severe sequelae due to hyperbilirubinemia can be prevented by early diagnosis and treatment. Massage is one of the applications that can be used to reduce bilirubin levels in newborn infants. Baby massage facilitates bowel movements and bilirubin excretion by reducing enterohepatic circulation. This study was designed as a randomized controlled trial to investigate the effect of massage on bilirubin levels in premature infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 6, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 18, 2019
CompletedFirst Submitted
Initial submission to the registry
September 18, 2019
CompletedFirst Posted
Study publicly available on registry
September 23, 2019
CompletedSeptember 27, 2019
September 1, 2019
1 year
September 18, 2019
September 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Transcutaneous Bilirubin Levels
bilirubin level mg/dl
"through study completion, an average of 1 year"
Secondary Outcomes (1)
frequency of defecation
"through study completion, an average of 1 year"
Other Outcomes (1)
length of hospital stay
"through study completion, an average of 1 year"
Study Arms (2)
Massage group
EXPERIMENTALTwice a day after the birth of the baby was massaged by the researcher for 5 days. Bilirubin levels were measured twice daily by the transcutaneous bilirubin meter before the morning massage and 2 hours after the evening massage for 5 days. In the morning (between 07:00-09:00 am) and in the evening (between 19:00-21:00 pm) twice a day, 15-20 minutes baby massage was applied.
Control group
NO INTERVENTIONThe control group who were administered standard care and bilirubin levels were measured twice daily by the transcutaneous bilirubin meter for 5 days
Interventions
Received baby massage and bilirubin levels were measured twice daily by the transcutaneous bilirubin meter for 5 days
Eligibility Criteria
You may qualify if:
- families being voluntary to participate in the study
- infants being born between 32 and 37 weeks plus 6 days of gestation
- infants having a birth weight of ≥1500 g
- infants having a fifth-minute Apgar score of more than seven
- infant's bilirubin level is not sufficient to require phototherapy
- the vital signs of the baby are within normal limits
- the absence of congenital major malformation of the infants
- the lack of patent ductus arteriosus requiring treatment
- no proven sepsis diagnosis
You may not qualify if:
- neonates with disease disrupting skin integrity (epidermolysis bullosa, ichthyosis, collodion baby)
- need for phototherapy
- infants with gastrointestinal obstruction and biliary atresia
- infants with congenital major deformations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ege Universitylead
Study Sites (1)
Ege University Faculty of Nursing
Izmir, Bornova, 35100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Hatice Bal Yılmaz, Prof.
Ege University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 18, 2019
First Posted
September 23, 2019
Study Start
April 6, 2018
Primary Completion
April 6, 2019
Study Completion
July 18, 2019
Last Updated
September 27, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share